Muutke küpsiste eelistusi

Hepatitis C: Care and Treatment: Volume 2 2021 ed. [Kõva köide]

Edited by
  • Formaat: Hardback, 219 pages, kõrgus x laius: 235x155 mm, kaal: 553 g, 24 Illustrations, color; 3 Illustrations, black and white, 1 Hardback
  • Ilmumisaeg: 11-May-2021
  • Kirjastus: Springer Nature Switzerland AG
  • ISBN-10: 3030677613
  • ISBN-13: 9783030677619
Teised raamatud teemal:
  • Kõva köide
  • Hind: 95,19 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 111,99 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 3-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
Hepatitis C: Care and Treatment: Volume 2 2021 ed.Suurem pilt
  • Formaat: Hardback, 219 pages, kõrgus x laius: 235x155 mm, kaal: 553 g, 24 Illustrations, color; 3 Illustrations, black and white, 1 Hardback
  • Ilmumisaeg: 11-May-2021
  • Kirjastus: Springer Nature Switzerland AG
  • ISBN-10: 3030677613
  • ISBN-13: 9783030677619
Teised raamatud teemal:
Püsilink: https://www.kriso.ee/db/9783030677619.html

This volume provides the reader with a detailed overview of the current state-of-the art approach of Hepatitis C management. It reviews the course of action in handling of chronic Hepatitis C patients with various HCV genotypes and treats special cases such as acute hepatitis, transplant and renal patients as well as people who inject drugs.

The two volume work on Hepatitis C introduces to the topic by reviewing virology, diagnosis, epidemiology, prevention, management and elimination of HCV. The book provides a valuable source at full length for researchers and clinicians working on Hepatitis C.

Assessment of liver disease severity.- Hepatitis C and autoimmunity.- Extrahepatic manifestations.- Treatment indications and pretreatment assessment.- Available agents - contraindications and potential drug-drug interactions.- Current management of patients with HCV genotype 1.- Current management of patients with HCV genotype 2.- Current management of patients with HCV genotype 3.- Current management of patients with HCV genotype 4.- Current management of patients with HCV genotype 5 or 6.- The role of RAVs in the current management of HCV.- Management of patients with HCV decompensated cirrhosis.- Management of patients with acute hepatitis C.- Management of transplant patients.- Management of immune complex-mediated manifestations of HCV.- Management of patients with co-infections (HBV, HIV).- Management of patients under hemodialysis.-Management of active drug addicts or patients on maintenance substitution.- Management of patients with hemoglobinopathies or bleeding disorders.- Follow-up during and after treatment.

Prof. Angelos Hatzakis MD, PhD National and Kapodistrian University of Athens, Medical School  Hepatitis B and C Public Policy Association